USP - Reference Standards

(3-(3-((((S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-5-hydroxy-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one)

((S)-2-Amino-3-[3-chloro-4-(4-hydroxy-3,5-diiodophenoxy)-5-iodophenyl]propanoic acid)

(5H-dibenzo[b,f]azepine-10,11-dione)

(Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-CoBeta-cyano-8Beta-hydroxycobamic a,b,d,e,g-pentaamide c,8-gamma-lactone)

(1-(4-(2-hydroxyethyl)phenoxy)-3-(isopropylamino)propan-2-ol)

(25 mg)

(N-Formyl-L-leucine(S)-1-[(2S,3S)-2-hydroxy-3-[1-phenyl-R-ethyl-carbomoyl]nonyl]-dodecyl ester)

(6,7,9,10-tetrahydro-8H-6,10-methanoazepino[4,5-g]quinoxaline-8-carbaldehyde)

(rel-(6S,10R)-2-methyl-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline)

(7,8,9,10-tetrahydro-8-methyl-6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine)

(3-(4-amino-5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione)

(25 mg

(3-((8R,9S,10R,13S,14S)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 17-(Pyridin-3-yl)androsta-3,5,16-triene)

(3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine)

(3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)

(N-[(1S,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide)

(N6-cyclopropyl-9H-purine-2,6-diamine)

(1-((8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl)ethan-1-one)

(3Beta-Chloro-17-(pyridin-3-yl)androsta-5,16-diene)

(2-amino-2-(4-nonylphenethyl)propane-1,3-diol)

(2-amino-2-(4-heptylphenethyl)propane-1,3-diol)